These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 33210739)
1. Variance-based sensitivity analysis for uncertainties in proton therapy: A framework to assess the effect of simultaneous uncertainties in range, positioning, and RBE model predictions on RBE-weighted dose distributions. Hofmaier J; Dedes G; Carlson DJ; Parodi K; Belka C; Kamp F Med Phys; 2021 Feb; 48(2):805-818. PubMed ID: 33210739 [TBL] [Abstract][Full Text] [Related]
2. Application of variance-based uncertainty and sensitivity analysis to biological modeling in carbon ion treatment plans. Kamp F; Wilkens JJ Med Phys; 2019 Feb; 46(2):437-447. PubMed ID: 30471124 [TBL] [Abstract][Full Text] [Related]
3. Quantifying the Dosimetric Impact of Proton Range Uncertainties on RBE-Weighted Dose Distributions in Intensity-Modulated Proton Therapy for Bilateral Head and Neck Cancer. Rana S; Manthala Padannayil N; Tran L; Rosenfeld AB; Saeed H; Kasper M Curr Oncol; 2024 Jun; 31(7):3690-3697. PubMed ID: 39057144 [TBL] [Abstract][Full Text] [Related]
4. Fast Biological Modeling for Voxel-based Heavy Ion Treatment Planning Using the Mechanistic Repair-Misrepair-Fixation Model and Nuclear Fragment Spectra. Kamp F; Cabal G; Mairani A; Parodi K; Wilkens JJ; Carlson DJ Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):557-68. PubMed ID: 26460998 [TBL] [Abstract][Full Text] [Related]
5. Quantification of the uncertainties of a biological model and their impact on variable RBE proton treatment plan optimization. Resch AF; Landry G; Kamp F; Cabal G; Belka C; Wilkens JJ; Parodi K; Dedes G Phys Med; 2017 Apr; 36():91-102. PubMed ID: 28410691 [TBL] [Abstract][Full Text] [Related]
6. Incorporation of relative biological effectiveness uncertainties into proton plan robustness evaluation. Ödén J; Eriksson K; Toma-Dasu I Acta Oncol; 2017 Jun; 56(6):769-778. PubMed ID: 28464736 [TBL] [Abstract][Full Text] [Related]
7. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy. Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161 [TBL] [Abstract][Full Text] [Related]
8. Significance and implementation of RBE variations in proton beam therapy. Paganetti H Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306 [TBL] [Abstract][Full Text] [Related]
9. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios. Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038 [TBL] [Abstract][Full Text] [Related]
10. The dirty and clean dose concept: Towards creating proton therapy treatment plans with a photon-like dose response. Heuchel L; Hahn C; Ödén J; Traneus E; Wulff J; Timmermann B; Bäumer C; Lühr A Med Phys; 2024 Jan; 51(1):622-636. PubMed ID: 37877574 [TBL] [Abstract][Full Text] [Related]
11. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors. Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671 [TBL] [Abstract][Full Text] [Related]
12. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy. Ödén J; Eriksson K; Toma-Dasu I Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554 [TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of dose-averaged linear energy transfer (LET Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809 [TBL] [Abstract][Full Text] [Related]
14. Analytical probabilistic modeling of RBE-weighted dose for ion therapy. Wieser HP; Hennig P; Wahl N; Bangert M Phys Med Biol; 2017 Nov; 62(23):8959-8982. PubMed ID: 28980974 [TBL] [Abstract][Full Text] [Related]
15. Investigating the impact of alpha/beta and LET Mara E; Clausen M; Khachonkham S; Deycmar S; Pessy C; Dörr W; Kuess P; Georg D; Gruber S Med Phys; 2020 Aug; 47(8):3691-3702. PubMed ID: 32347564 [TBL] [Abstract][Full Text] [Related]
16. Impact of uncertainties in range and RBE on small field proton therapy. Marteinsdottir M; Schuemann J; Paganetti H Phys Med Biol; 2019 Oct; 64(20):205005. PubMed ID: 31519016 [TBL] [Abstract][Full Text] [Related]
17. Investigating the robustness of ion beam therapy treatment plans to uncertainties in biological treatment parameters. Böhlen TT; Brons S; Dosanjh M; Ferrari A; Fossati P; Haberer T; Patera V; Mairani A Phys Med Biol; 2012 Dec; 57(23):7983-8004. PubMed ID: 23154750 [TBL] [Abstract][Full Text] [Related]
18. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions. Henry T; Ödén J Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384 [TBL] [Abstract][Full Text] [Related]
19. Quantification of biological range uncertainties in patients treated at the Krakow proton therapy centre. Garbacz M; Gajewski J; Durante M; Kisielewicz K; Krah N; Kopeć R; Olko P; Patera V; Rinaldi I; Rydygier M; Schiavi A; Scifoni E; Skóra T; Skrzypek A; Tommasino F; Rucinski A Radiat Oncol; 2022 Mar; 17(1):50. PubMed ID: 35264184 [TBL] [Abstract][Full Text] [Related]
20. Clinical consequences of relative biological effectiveness variations in proton radiotherapy of the prostate, brain and liver. Carabe A; España S; Grassberger C; Paganetti H Phys Med Biol; 2013 Apr; 58(7):2103-17. PubMed ID: 23470339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]